分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery

Zhou Tian, Zhu Xinyi, Ye Zhizhong, Wang Yong-Fei, Yao Chao, Xu Ning, Zhou Mi, Ma Jianyang, Qin Yuting, Shen Yiwei, Tang Yuanjia, Yin Zhihua, Xu Hong, Zhang Yutong, Zang Xiaoli, Ding Huihua, Yang Wanl

Journal:Nature Communications

IF:17.69

DOI:10.1038/s41467-022-29514-y

PMID:35388006

Published:2022-04-06

research field:分子生物学电化学生物技术癌症诊断

Abstract

Despite strong evidence that human genetic variants affect the expression of many key transcription factors involved in autoimmune diseases, establishing biological links between non-coding risk variants and the gene targets they regulate remains a considerable challenge. Here, we combine genetic, epigenomic, and CRISPR activation approaches to screen for functional variants that regulate IRF8 expression. We demonstrate that the locus containing rs2280381 is a cell-type-specific enhancer for IRF8 that spatially interacts with the IRF8 promoter. Further, rs2280381 mediates IRF8 expression through enhancer RNA AC092723.1, which recruits TET1 to the IRF8 promoter regulating IRF8 expression by affecting methylation levels. The alleles of rs2280381 modulate PU.1 binding and chromatin state to regulate AC092723.1 and IRF8 expression differentially. Our work illustrates an integrative strategy to define functional genetic variants that regulate the expression of critical genes in autoimmune diseases and decipher the mechanisms underlying the dysregulation of IRF8 expression mediated by lupus risk variants.

本文使用的Yeasen产品

购物车
客服
转染试用